Multiple Sclerosis (MS)

This is our library on scientific research related to CBD, the Endocannabinoid System, other cannabinoids and Multiple Sclerosis (MS). Below you will find a list of conditions for which there are one or more scientific studies of CBD. The source of these scientific studies relates primarily to PubMed, an online service of the U.S. National Library of Medicine.

Important: The studies that are listed by PubMed are for the most part preclinical research. These relate in most cases to animal experiments with isolated CBD (pure CBD) and not fully extracted CBD extract. Although mammals have cell receptors that respond to cannabinoid compounds, the data collected from animal studies are not always 1: 1 applicable to humans. Always check with your physician before starting a new dietary supplement program. Learn more at: The Basics of CBD Oils and Cannabis as a Therapeutic Agent

A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis
CBD counteracted the development of experimental MS
CBD provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
CBD/THC Oromucosal Spray for Multiple Sclerosis-Related Resistant Spasticity in Daily Practice
Clinical efficacy and effectiveness of Sativex, a combined cannabinoid medicine, in multiple sclerosis-related spasticity
Evaluating Sativex in Neuropathic Pain Management
Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain
Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis
Neurological aspects of medical use of CBD
Oromucosal delta9-THC/CBD for neuropathic pain associated with multiple sclerosis 
Sativex for the management of multiple sclerosis symptoms
Sativex long-term use: An open-label trial in patients with spasticity due to multiple sclerosis
Sativex: Clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain
THC & CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis

Send this to a friend